论文部分内容阅读
本文选择我院1964-1966年鼻咽癌2000例及1979-1980年1000例的临床资料进行对比分析。认为近十三年来鼻咽癌的发病因素和生物学特性是相对稳定的。发现相隔十三年,早期(ⅠⅡ期)诊断率提高了31.25％,晚期(ⅡⅣ期)病例相应减少了。这与近年来我们加强了防癌知识宣传、群众和基层医务人员的癌瘤知识提高有关。因而来诊时间较前提早,症状及病情有所减轻。 但是Ⅰ期病例的诊断率仍低(平均4.5％),要提高早诊率,不能单靠病人出现耳鼻症状才来诊,大规模人群普查耗费又巨大。认为EB病毒血清学检测可以克服上述缺点。今后应继续加强对Ⅰ期病人的临床特性分析,EB病毒血清学及鼻咽粘膜癌前期病变等多种早期诊断方法的研究。
This article selected the clinical data of 2000 cases of nasopharyngeal carcinoma in our hospital from 1964 to 1966 and 1000 cases from 1979 to 1980 for comparative analysis. It is believed that the incidence and biological characteristics of nasopharyngeal carcinoma are relatively stable in the past 13 years. Found that 13 years apart, the early (phase III) diagnostic rate increased by 31.25%, and late (IIIV) cases decreased accordingly. This is related to the fact that in recent years we have stepped up the promotion of anti-cancer knowledge and the increase in cancer awareness among the masses and grass-roots medical personnel. Therefore, the arrival time is earlier than before, and the symptoms and conditions are reduced. However, the diagnostic rate of stage I cases is still low (average 4.5%). To increase the rate of early diagnosis, it is not possible to rely on the patient’s ear and nose symptoms alone. The large-scale population survey is expensive. It is considered that the EB virus serological test can overcome the above disadvantages. In the future, we should continue to strengthen the analysis of clinical characteristics of stage I patients, EB virus serology, and early stage diagnosis of nasopharyngeal mucosal precancerous lesions.